Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients-Reference-Cited by-同舟云学术

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8+T-cell responses in melanoma patients

Published:2012-08-28 Issue:11 Volume:42 Page:3049-3061
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Goldinger Simone M.¹,Dummer Reinhard¹,Baumgaertner Petra²³,Mihic-Probst Daniela¹,Schwarz Katrin⁴,Hammann-Haenni Anya⁴,Willers Joerg⁴,Geldhof Christine²³,Prior John O.²³,Kündig Thomas M.¹,Michielin Olivier²³,Bachmann Martin F.⁴,Speiser Daniel E.²³

Affiliation:

1. Dermatology and Pathology Departments; University Hospital of Zurich; Zurich Switzerland

2. Clinical Tumor Biology & Immunotherapy Unit; Ludwig Center of the University of Lausanne; Lausanne Switzerland

3. Nuclear Medicine Department, University Hospital Center; Lausanne Switzerland

4. Cytos Biotechnology AG; Schlieren-Zurich Switzerland

Funder

Swiss Cancer League

Swiss National Science Foundation

Ludwig Institute for Cancer Research

Cancer Research Institute (USA)

Cancer Vaccine Collaborative (USA)

Gottfried and Julia Bangeter Foundation (Switzerland)

Schnyder Foundation (Switzerland)

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201142361/fullpdf

Reference47 articles.

1. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens;Dudley;J. Clin. Oncol.,2008

2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2011

3. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N. Engl. J. Med.,2011

4. Cancer immunotherapy: moving beyond current vaccines;Rosenberg;Nat. Med.,2004

5. Immunotherapy: vaccine trials in melanoma - time for reflection;Eggermont;Nat. Rev. Clin. Oncol.,2009

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives;Chemical Engineering Journal;2024-04

2. TLR AND CANCER: THE ENIGMATIC CROSS TALK;Thirty Years since the Discovery of Toll-Like Receptors;2024-03-20

3. Poly(I:C) and R848 ligands show better adjuvanticity to induce B and T cell responses against the antigen(s);Heliyon;2024-03

4. Peptide nanovaccine in melanoma immunotherapy;International Immunopharmacology;2024-03

5. A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms;Experimental Biology and Medicine;2024-01-31